This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the
efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in
subjects with Alzheimer's disease (AD) and controls during lifetime when compared to
histopathology obtained after death and completion of brain autopsy.